会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHODS AND KITS FOR DETECTING RISK FACTORS FOR DEVELOPMENT OF JAW OSTEONECROSIS AND METHODS OF TREATMENT THEREOF
    • 用于检测颌骨骨软骨发育风险因子的方法和试剂盒及其治疗方法
    • WO2011084387A3
    • 2011-10-27
    • PCT/US2010060139
    • 2010-12-13
    • UNIV FLORIDAKATZ JOSEPHLANGAEE TAIMOUR Y
    • KATZ JOSEPHLANGAEE TAIMOUR Y
    • C12Q1/68C12N15/12
    • C12Q1/6883C12Q2600/156C12Q2600/172
    • Methods of and kits for determining the pharmacogenetic, pharmacokinetic and cellular basis of bisphosphonate-induced osteonecrosis of the jaw (BONJ) involve associating particular proteins and particular single nucleotide polymorphisms with a risk for developing BONJ after receiving bisphosphonate treatment. Methods and kits for identifying the genetic basis for a patient's predisposition to BONJ, and methods of identifying patients who are prone to develop BONJ following bisphosphonate administration provide for the development of a tool for physicians to prescribe treatment protocols for BONJ patients based on the patients' genomes ("personal/tailored medicine"). A haplotype tagging SNP approach was used to analyze candidate genes involved in bone absorption and destruction and to examine the influence of genetic variants on the susceptibility of BONJ. Bone biomarkers of BONJ were examined using molecular cell techniques. The methods described herein can be used to identify differences in how patients are genetically predisposed to BONJ as well as genetic differences amongst patients that account for differences in how these patients clear bisphosphonate s from their systems. Determining such genetic differences provides for improved monitoring of the drugs used to treat BONJ, improved prevention of BONJ, and optimized treatment for patients having BONJ or predisposed to BONJ.
    • 用于确定双膦酸盐诱导的颌骨骨坏死(BONJ)的药物遗传学,药代动力学和细胞基础的方法和试剂盒涉及使特定蛋白质和特定的单核苷酸多态性与接受双磷酸盐治疗后发生BONJ的风险相关联。 用于鉴定患者对BONJ易感性的遗传基础的方法和试剂盒以及鉴定在施用双膦酸盐后容易发生BONJ的患者的方法提供了开发一种工具,用于医师根据患者的情况为BONJ患者规定治疗方案, 基因组(“个人/定制医学”)。 使用单体型标记SNP方法分析参与骨吸收和破坏的候选基因,并检查遗传变体对BONJ易感性的影响。 使用分子细胞技术检查BONJ的骨生物标志物。 本文所述的方法可用于鉴定患者如何遗传易感BONJ的差异以及患者之间的遗传差异,这些差异解释了这些患者如何从其系统中清除二膦酸盐。 确定此类遗传差异可改善对用于治疗BONJ的药物的监测,改善对BONJ的预防,以及对患有BONJ或易患BONJ的患者的优化治疗。
    • 5. 发明申请
    • METHODS AND KITS FOR DETECTING RISK FACTORS FOR DEVELOPMENT OF JAW OSTEONECROSIS AND METHODS OF TREATMENT THEREOF
    • 检测风险因素的方法和检测手段,用于发展AW AW AW AW R IS IS IS IS OF OF OF OF OF OF OF OF OF OF
    • WO2011084387A2
    • 2011-07-14
    • PCT/US2010/060139
    • 2010-12-13
    • UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.KATZ, JosephLANGAEE, Taimour, Y.
    • KATZ, JosephLANGAEE, Taimour, Y.
    • C12Q1/68C12N15/12
    • C12Q1/6883C12Q2600/156C12Q2600/172
    • Methods of and kits for determining the pharmacogenetic, pharmacokinetic and cellular basis of bisphosphonate-induced osteonecrosis of the jaw (BONJ) involve associating particular proteins and particular single nucleotide polymorphisms with a risk for developing BONJ after receiving bisphosphonate treatment. Methods and kits for identifying the genetic basis for a patient's predisposition to BONJ, and methods of identifying patients who are prone to develop BONJ following bisphosphonate administration provide for the development of a tool for physicians to prescribe treatment protocols for BONJ patients based on the patients' genomes ("personal/tailored medicine"). A haplotype tagging SNP approach was used to analyze candidate genes involved in bone absorption and destruction and to examine the influence of genetic variants on the susceptibility of BONJ. Bone biomarkers of BONJ were examined using molecular cell techniques. The methods described herein can be used to identify differences in how patients are genetically predisposed to BONJ as well as genetic differences amongst patients that account for differences in how these patients clear bisphosphonate s from their systems. Determining such genetic differences provides for improved monitoring of the drugs used to treat BONJ, improved prevention of BONJ, and optimized treatment for patients having BONJ or predisposed to BONJ.
    • 用于测定双膦酸盐诱导的颌骨骨坏死(BONJ)的药物遗传学,药代动力学和细胞学基础的方法和试剂盒涉及将具体的蛋白质和具体的单核苷酸多态性与接受双膦酸盐治疗后发生BONJ的风险相关联。 用于鉴定患者对BONJ倾向的遗传基础的方法和试剂盒,以及鉴定双膦酸盐给药后容易发展BONJ的患者的方法,为医师开发出一种工具,用于根据患者的BONJ开发BONJ患者的治疗方案, 基因组(“个人/定制药”)。 使用单倍型标记SNP方法分析参与骨吸收和破坏的候选基因,并检查遗传变异对BONJ敏感性的影响。 使用分子细胞技术检查BONJ的骨生物标志物。 本文描述的方法可以用于鉴定患者如何遗传易感BONJ的差异以及患者之间的遗传差异,这些差异表明这些患者如何从其系统中清除双膦酸盐。 确定这样的遗传差异提供改进的用于治疗BONJ的药物的监测,改善BONJ的预防,以及对具有BONJ或倾向于BONJ的患者的优化治疗。
    • 7. 发明申请
    • THE SEPARATION, IDENTIFICATION AND QUANTITATION OF PROTEIN MIXTURES
    • 蛋白质混合物的分离,鉴定和定量
    • WO02060377A3
    • 2003-01-03
    • PCT/US0147754
    • 2001-12-14
    • UNIV JOHNS HOPKINSKATZ JOSEPH LWIRTZ DENIS
    • KATZ JOSEPH LWIRTZ DENIS
    • B01J19/00G01N33/543G01N33/553G01N33/53G01N33/537
    • B01J19/0093B01J2219/00864B01J2219/00952G01N33/54326
    • A Repeated Classification Procedure (RCP) for the rapid separation, identification, classification, and quantitation of proteins in a mixture of proteins utilizes general-motif antibodies which typically bind to a plurality of proteins in a mixture which have a common motif or are homologs in some respect. By repeatedly using general-motif antibodies or using general-motif antibodies in conjunction with specific antibodies, a pattern of binding can be produced which uniquely identifies proteins of interest. By using immobilized general-motif antibodies to effect separation, the identification, classification, and quantitation of proteins in a sample can be use to characterize the protein synthesis pattern of disease states. Quantitation of protein in a sample can be determined based on the movement of very small beads with bound protein in a magnetic field, wherein larger quantities of bound protein causes the beads to travel relatively smaller distances or at relatively slower rates.
    • 用于蛋白质混合物中蛋白质的快速分离,鉴定,分类和定量的重复分类程序(RCP)利用通常基序抗体,其通常结合具有共同基序或同系物的混合物中的多种蛋白质 一些尊重 通过重复使用一般基序抗体或使用一般基序抗体与特异性抗体结合,可以产生唯一识别感兴趣蛋白质的结合模式。 通过使用固定的一般基序抗体来实现分离,样品中蛋白质的鉴定,分类和定量可用于表征疾病状态的蛋白质合成模式。 可以基于磁场中具有结合蛋白质的非常小的珠粒的移动来确定样品中的蛋白质的定量,其中较大量的结合蛋白质导致珠粒行进相对较小的距离或以相对较慢的速率行进。
    • 8. 发明申请
    • THE SEPARATION, IDENTIFICATION AND QUANTITATION OF PROTEIN MIXTURES
    • 蛋白质混合物的分离,鉴定和定量
    • WO2002060377A2
    • 2002-08-08
    • PCT/US2001/047754
    • 2001-12-14
    • THE JOHNS HOPKINS UNIVERSITYKATZ, Joseph, L.WIRTZ, Denis
    • KATZ, Joseph, L.WIRTZ, Denis
    • A61K
    • B01J19/0093B01J2219/00864B01J2219/00952G01N33/54326
    • A Repeated Classification Procedure (RCP) for the rapid separation, identification, classification, and quantitation of proteins in a mixture of proteins utilizes general-motif antibodies which typically bind to a plurality of proteins in a mixture which have a common motif or are homologs in some respect. By repeatedly using general-motif antibodies or using general-motif antibodies in conjunction with specific antibodies, a pattern of binding can be produced which uniquely identifies proteins of interest. By using immobilized general-motif antibodies to effect separation, the identification, classification, and quantitation of proteins in a sample can be use to characterize the protein synthesis pattern of disease states. Quantitation of protein in a sample can be determined based on the movement of very small beads with bound protein in a magnetic field, wherein larger quantities of bound protein causes the beads to travel relatively smaller distances or at relatively slower rates.
    • 用于蛋白质混合物中蛋白质的快速分离,鉴定,分类和定量的重复分类程序(RCP)利用通常基序抗体,其通常结合具有共同基序或同系物的混合物中的多种蛋白质 一些尊重 通过重复使用一般基序抗体或使用一般基序抗体与特异性抗体结合,可以产生唯一识别感兴趣蛋白质的结合模式。 通过使用固定的一般基序抗体来实现分离,样品中蛋白质的鉴定,分类和定量可用于表征疾病状态的蛋白质合成模式。 可以基于磁场中具有结合蛋白质的非常小的珠粒的移动来确定样品中的蛋白质的定量,其中较大量的结合蛋白质导致珠粒行进相对较小的距离或以相对较慢的速率行进。